Inhibikase Therapeutics Ownership | Who Owns Inhibikase Therapeutics?

Inhibikase Therapeutics Ownership Summary

Inhibikase Therapeutics is owned by 0.05% institutional investors, and 99.95% retail investors. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.13% of its assets in Inhibikase Therapeutics shares.

IKT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Inhibikase Therapeutics	0.05%	-	99.95%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2023	1	-94.12%	13,802	-99.69%	-	0.02%	-	-100.00%	1	-50.00%
Mar 31, 2023	17	-10.53%	4,421,111	206.88%	16	49.22%	7	-22.22%	2	-60.00%
Dec 31, 2022	19	-13.64%	1,440,673	-52.69%	5	3.92%	9	80.00%	5	25.00%
Sep 30, 2022	22	10.00%	3,045,355	-9.10%	12	6.84%	5	-50.00%	4	-
Jun 30, 2022	20	-13.04%	3,350,331	-21.64%	13	4.62%	10	25.00%	4	-33.33%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	2.28M	3.13%	-
Vanguard Institutional Extnd Mkt Idx Tr	483.35K	0.67%	-
Fidelity Extended Market Index	150.50K	0.20%	-959.00
Fidelity Total Market Index	60.11K	0.08%	-48.00
Extended Equity Market Fund K	54.50K	0.07%	740.00
Vanguard Balanced Index Inv	44.36K	0.06%	-
Fidelity Series Total Market Index	38.35K	0.05%	-
Vanguard Instl Ttl Stck Mkt Idx Tr	33.54K	0.05%	33.54K
Timber Point Global Allocations Instl	35.00K	0.05%	24.00K
Vanguard Instl Ttl Stk Mkt Idx InstlPls	33.54K	0.05%	-

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q4	3	-
2024 Q3	-	-
2024 Q2	-	-
2023 Q2	-	-

IKT Ownership FAQ

Who Owns Inhibikase Therapeutics?

Inhibikase Therapeutics shareholders are primarily institutional investors at 0.05%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Inhibikase Therapeutics's industry, Biotech Stocks , is 68.48%, which Inhibikase Therapeutics falls below.

Does Blackrock own Inhibikase Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Inhibikase Therapeutics.

Who is the top mutual fund holder of Inhibikase Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Inhibikase Therapeutics shares, with 3.13% of its total shares outstanding invested in 2.28M Inhibikase Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools